Defining the seasonality of respiratory syncytial virus around the world: National and subnational surveillance data from 12 countriesLisa Staadegaard, John Paget, Saverio Caini et al.|Influenza and Other Respiratory Viruses|2021Cited by 128
The Global Epidemiology of RSV in Community and Hospitalized Care: Findings From 15 CountriesLisa Staadegaard, John Paget, Tim Wood et al.|Open Forum Infectious Diseases|2021Cited by 91
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021Esther Kissling, Mariëtte Hooiveld, Virginia Martin et al.|Eurosurveillance|2021Cited by 55
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024Marine Maurel, Jennifer Howard, Esther Kissling et al.|Eurosurveillance|2024Cited by 50
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre studyEsther Kissling, Francisco Pozo, Iván Martínez‐Baz et al.|Influenza and Other Respiratory Viruses|2022Cited by 45